• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
D-dimer, thrombin generation, and risk of a first venous thrombosis in the elderly.D-二聚体、凝血酶生成与老年人首次发生静脉血栓形成的风险
Res Pract Thromb Haemost. 2021 Jun 21;5(5):e12536. doi: 10.1002/rth2.12536. eCollection 2021 Jul.
2
The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study.与 D-二聚体水平升高和凝血酶潜力升高相关的首次和复发性静脉血栓形成的风险:THE-VTE 研究结果。
J Thromb Haemost. 2015 Sep;13(9):1642-52. doi: 10.1111/jth.13043. Epub 2015 Aug 27.
3
Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer.通过内源性凝血酶潜力和D - 二聚体预测复发性静脉血栓栓塞症
Clin Chem. 2008 Dec;54(12):2042-8. doi: 10.1373/clinchem.2008.112243. Epub 2008 Oct 23.
4
Diagnostic Accuracy in Acute Venous Thromboembolism: Comparing D-Dimer, Thrombin Generation, Overall Hemostatic Potential, and Fibrin Monomers.急性静脉血栓栓塞症的诊断准确性:比较D - 二聚体、凝血酶生成、整体止血潜力和纤维蛋白单体
TH Open. 2020 Aug 20;4(3):e178-e188. doi: 10.1055/s-0040-1714210. eCollection 2020 Jul.
5
A thrombin generation assay may reduce the need for compression ultrasonography for the exclusion of deep venous thrombosis in the elderly.在老年人群中,使用凝血酶原时间测定法(一种检测凝血功能的方法)可能有助于减少对深静脉血栓形成的超声检查的需求。
Scand J Clin Lab Invest. 2011 Feb;71(1):12-8. doi: 10.3109/00365513.2010.534173. Epub 2010 Nov 15.
6
Prolonged clot lysis time increases the risk of a first but not recurrent venous thrombosis.凝血时间延长会增加首次发生静脉血栓形成的风险,但不会增加复发风险。
Br J Haematol. 2016 Mar;172(6):947-53. doi: 10.1111/bjh.13911. Epub 2016 Jan 15.
7
Procoagulant factor levels and risk of venous thrombosis in the elderly.老年人促凝血因子水平与静脉血栓形成风险
J Thromb Haemost. 2021 Jan;19(1):186-193. doi: 10.1111/jth.15127. Epub 2020 Dec 22.
8
Effect of selected prothrombotic and proinflammatory factors on the incidence of venous thrombosis after pacemaker implantation.选定的促血栓形成和促炎因子对起搏器植入后静脉血栓形成发生率的影响。
Kardiol Pol. 2012;70(3):260-7.
9
Genetic risk factors for venous thrombosis in the elderly in a case-control study.老年静脉血栓形成的遗传危险因素:病例对照研究。
J Thromb Haemost. 2016 Sep;14(9):1759-64. doi: 10.1111/jth.13409. Epub 2016 Aug 26.
10
Thrombin generation in ankylosing spondylitis.强直性脊柱炎患者的凝血酶生成。
Clin Rheumatol. 2011 Apr;30(4):511-4. doi: 10.1007/s10067-010-1552-x. Epub 2010 Aug 17.

引用本文的文献

1
Thrombin generation indices and Wells score predict pulmonary embolism in patients with acute exacerbation of chronic obstructive pulmonary disease.凝血酶生成指数和Wells评分可预测慢性阻塞性肺疾病急性加重患者的肺栓塞。
Clinics (Sao Paulo). 2025 Feb 27;80:100582. doi: 10.1016/j.clinsp.2025.100582. eCollection 2025.
2
Mice with reduced protease-activated receptor 4 reactivity show decreased venous thrombosis and platelet procoagulant activity.蛋白酶激活受体4反应性降低的小鼠表现出静脉血栓形成减少和血小板促凝活性降低。
J Thromb Haemost. 2025 Apr;23(4):1278-1288. doi: 10.1016/j.jtha.2024.12.031. Epub 2025 Jan 9.
3
Mice with Reduced PAR4 Reactivity show Decreased Venous Thrombosis and Platelet Procoagulant Activity.PAR4反应性降低的小鼠静脉血栓形成及血小板促凝活性降低。
bioRxiv. 2024 Oct 17:2024.10.14.617127. doi: 10.1101/2024.10.14.617127.
4
A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity.蛋白酶激活受体4 Pro310Leu变体的小鼠模型血小板反应性降低。
J Thromb Haemost. 2024 Jun;22(6):1715-1726. doi: 10.1016/j.jtha.2024.03.004. Epub 2024 Mar 19.
5
Association between venous thromboembolism-associated genetic variants, coagulation factor levels, and thrombin generation potential.静脉血栓栓塞相关基因变异、凝血因子水平与凝血酶生成潜能之间的关联。
EJHaem. 2024 Feb 18;5(1):47-54. doi: 10.1002/jha2.863. eCollection 2024 Feb.
6
Thrombin Generation Is Associated with Venous Thromboembolism Recurrence, but Not with Major Bleeding and Death in the Elderly: A Prospective Multicenter Cohort Study.凝血酶生成与静脉血栓栓塞复发相关,但与老年人的大出血和死亡无关:一项前瞻性多中心队列研究。
J Clin Med. 2023 Sep 19;12(18):6050. doi: 10.3390/jcm12186050.
7
Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism.血浆补体因子 H 相关蛋白 5 升高与静脉血栓栓塞相关。
Nat Commun. 2023 Jun 7;14(1):3280. doi: 10.1038/s41467-023-38383-y.
8
Point-of-Care Platform for Diagnosis of Venous Thrombosis by Simultaneous Detection of Thrombin Generation and D-Dimer in Human Plasma.即时检测平台,用于同时检测人血浆中的凝血酶生成和 D-二聚体,以诊断静脉血栓形成。
Anal Chem. 2023 Jan 17;95(2):1115-1122. doi: 10.1021/acs.analchem.2c03819. Epub 2022 Dec 21.

本文引用的文献

1
Thrombin generation profile in non-thrombotic factor V Leiden carriers.非血栓形成性因子 V Leiden 携带者的凝血酶生成谱。
J Thromb Thrombolysis. 2019 Apr;47(3):473-477. doi: 10.1007/s11239-019-01821-0.
2
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.瑞舒伐他汀可降低静脉血栓栓塞患者的凝血酶生成潜能:一项随机对照试验。
J Thromb Haemost. 2019 Feb;17(2):319-328. doi: 10.1111/jth.14364. Epub 2019 Feb 3.
3
Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.静脉血栓栓塞症的诊断标志物:D-二聚体、凝血酶生成、促凝血磷脂和可溶性 P-选择素。
J Clin Pathol. 2018 Nov;71(11):1015-1022. doi: 10.1136/jclinpath-2018-205293. Epub 2018 Aug 9.
4
A review of commercially available thrombin generation assays.市售凝血酶生成检测方法综述。
Res Pract Thromb Haemost. 2017 Oct 16;2(1):42-48. doi: 10.1002/rth2.12048. eCollection 2018 Jan.
5
The DiPEP (Diagnosis of PE in Pregnancy) biomarker study: An observational cohort study augmented with additional cases to determine the diagnostic utility of biomarkers for suspected venous thromboembolism during pregnancy and puerperium.DiPEP(妊娠期间 PE 的诊断)生物标志物研究:一项观察性队列研究,增加了额外的病例,以确定生物标志物在妊娠和产褥期疑似静脉血栓栓塞症中的诊断效用。
Br J Haematol. 2018 Mar;180(5):694-704. doi: 10.1111/bjh.15102. Epub 2018 Jan 23.
6
Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.长期低分子量肝素抗凝治疗对癌症合并静脉血栓栓塞症患者凝血酶生成及D - 二聚体的影响
Cancer Invest. 2017 Aug 9;35(7):490-499. doi: 10.1080/07357907.2017.1340480. Epub 2017 Jul 10.
7
Thrombin Generation in Patients With Suspected Venous Thromboembolism.疑似静脉血栓栓塞症患者的凝血酶生成
Clin Appl Thromb Hemost. 2017 Jul;23(5):416-421. doi: 10.1177/1076029617700999. Epub 2017 Mar 24.
8
Thrombin Generation Assay and Its Application in the Clinical Laboratory.凝血酶生成试验及其在临床实验室中的应用。
Clin Chem. 2016 May;62(5):699-707. doi: 10.1373/clinchem.2015.248625. Epub 2016 Mar 8.
9
The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study.与 D-二聚体水平升高和凝血酶潜力升高相关的首次和复发性静脉血栓形成的风险:THE-VTE 研究结果。
J Thromb Haemost. 2015 Sep;13(9):1642-52. doi: 10.1111/jth.13043. Epub 2015 Aug 27.
10
Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants.高凝状态:实验室检测的算法方法及直接口服抗凝剂监测的更新
Blood Res. 2014 Jun;49(2):85-94. doi: 10.5045/br.2014.49.2.85. Epub 2014 Jun 25.

D-二聚体、凝血酶生成与老年人首次发生静脉血栓形成的风险

D-dimer, thrombin generation, and risk of a first venous thrombosis in the elderly.

作者信息

Wang Huijie, Rosendaal Frits R, Cushman Mary, van Hylckama Vlieg Astrid

机构信息

Department of Clinical Epidemiology Leiden University Medical Center Leiden The Netherlands.

Department of Medicine Larner College of Medicine at the University of Vermont Burlington Vermont USA.

出版信息

Res Pract Thromb Haemost. 2021 Jun 21;5(5):e12536. doi: 10.1002/rth2.12536. eCollection 2021 Jul.

DOI:10.1002/rth2.12536
PMID:34263100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8268666/
Abstract

BACKGROUND

A high D-dimer level and parameters of the thrombin generation (TG) potential are associated with the risk of a first venous thrombosis (VT) in young and middle-aged populations.

OBJECTIVES

To investigate whether D-dimer and TG potential (lag-time, time-to-peak [ttPeak], peak thrombin, endogenous thrombin potential [ETP], and velocity index), are associated with the risk of a first VT in those aged 70 years and older.

METHODS

We included 215 patients with a first VT and 358 controls, all aged >70 years, from the Age and Thrombosis, Acquired and Genetic Risk Factors in the Elderly (AT-AGE) study. To assess the risk of VT, odds ratios with 95% confidence intervals (CIs) were estimated using logistic regression analysis.

RESULTS

D-dimer and all TG parameters except lag time were associated with an increased risk of VT in a dose-response manner. Comparing the fourth with the first quartile (for ttPeak comparing the first with the fourth quartile), risk estimates were: 7.8 (95% CI, 4.0-15.0) for peak, 2.0 (95% CI, 1.2-3.3) for ttPeak, 9.1 (95% CI, 4.4-18.9) for ETP, and 11.5 (95% CI, 5.7-23.3) for velocity index. Comparing the highest quartile of D-dimer with the lowest, the risk was 7.7-fold increased (95% CI, 4.0-14.8). Furthermore, all factors also increased the risk of VT after dichotomizing at more extreme cutoff values. The risk of VT was further increased in the presence of multiple prothrombotic TG parameters and elevated D-dimer level or in combination with prothrombotic mutations.

CONCLUSIONS

D-dimer and TG parameters (except lag time) are associated with the risk of first VT in elderly population.

摘要

背景

在年轻和中年人群中,高D-二聚体水平和凝血酶生成(TG)潜能参数与首次静脉血栓形成(VT)风险相关。

目的

调查D-二聚体和TG潜能(滞后时间、达到峰值时间[ttPeak]、凝血酶峰值、内源性凝血酶潜能[ETP]和速度指数)是否与70岁及以上人群首次VT风险相关。

方法

我们纳入了来自老年人群年龄与血栓形成、获得性和遗传风险因素(AT-AGE)研究的215例首次发生VT的患者和358例对照,所有患者年龄均大于70岁。为评估VT风险,采用逻辑回归分析估计95%置信区间(CI)的比值比。

结果

D-二聚体和除滞后时间外的所有TG参数均以剂量反应方式与VT风险增加相关。将第四个四分位数与第一个四分位数进行比较(对于ttPeak,将第一个四分位数与第四个四分位数进行比较),风险估计值如下:凝血酶峰值为7.8(95%CI,4.0-15.0),ttPeak为2.0(95%CI,1.2-3.3),ETP为9.1(95%CI,4.4-18.9),速度指数为11.5(95%CI,5.7-23.3)。将D-二聚体的最高四分位数与最低四分位数进行比较,风险增加7.7倍(95%CI,4.0-14.8)。此外,在更极端的临界值进行二分法后,所有因素也增加了VT风险。在存在多个促血栓形成TG参数和D-二聚体水平升高或与促血栓形成突变联合存在时,VT风险进一步增加。

结论

D-二聚体和TG参数(除滞后时间外)与老年人群首次VT风险相关。